The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[(1S)-1-[4-cyano-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-5-yl]-7-oxo-nonyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide ID: ALA4797893
PubChem CID: 162675870
Max Phase: Preclinical
Molecular Formula: C29H36F3N5O2
Molecular Weight: 543.63
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)CCCCC[C@H](NC(=O)[C@H]1CC12CCN(C)CC2)c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc1C#N
Standard InChI: InChI=1S/C29H36F3N5O2/c1-3-21(38)7-5-4-6-8-23(35-27(39)22-17-28(22)13-15-37(2)16-14-28)25-24(18-33)34-26(36-25)19-9-11-20(12-10-19)29(30,31)32/h9-12,22-23H,3-8,13-17H2,1-2H3,(H,34,36)(H,35,39)/t22-,23+/m1/s1
Standard InChI Key: QSAPXBCUKYHAFP-PKTZIBPZSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
9.6288 -6.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0374 -7.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8505 -7.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2611 -6.8828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8566 -6.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0374 -6.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2261 -5.4355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2249 -6.2592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9371 -6.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6509 -6.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6481 -5.4319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9353 -5.0225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3561 -5.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1080 -5.3477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6567 -4.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2413 -4.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4385 -4.2011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4738 -4.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8090 -5.5702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9517 -4.1537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7688 -4.2360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2508 -3.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0680 -3.6513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5458 -2.9884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3630 -3.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8449 -2.4037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7023 -3.8202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6621 -2.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6262 -5.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9614 -6.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1082 -4.9855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8798 -7.2179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0824 -6.8865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5754 -3.2773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9046 -2.5294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5174 -6.6681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8095 -6.2599 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5178 -7.4853 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.8036 -7.0699 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 2 0
11 13 1 0
15 18 1 0
18 19 1 6
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
19 29 1 0
30 29 1 6
29 31 2 0
32 30 1 0
1 32 1 0
30 1 1 0
4 33 1 0
34 35 3 0
16 34 1 0
8 36 1 0
36 37 1 0
36 38 1 0
36 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.63Molecular Weight (Monoisotopic): 543.2821AlogP: 5.79#Rotatable Bonds: 11Polar Surface Area: 101.88Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.99CX Basic pKa: 8.83CX LogP: 4.63CX LogD: 3.43Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -0.43
References 1. Clausen DJ,Liu J,Yu W,Duffy JL,Chung CC,Myers RW,Klein DJ,Fells J,Holloway K,Wu J,Wu G,Howell BJ,Barnard RJO,Kozlowski J. (2020) Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir., 30 (17.0): [PMID:32738976 ] [10.1016/j.bmcl.2020.127367 ]